{"changeSha256":"3c6c100f9c2a9a3faa80deaa4e02f089300298e5ac2e65180304bffc215e9eee","changedAt":"2026-11-14","changedFields":[{"after":"FDA-approved as Imcivree for specific rare causes of obesity","before":"U.S. label record","field":"Status"},{"after":"An MC4 receptor agonist approved by FDA as Imcivree for acquired hypothalamic obesity, Bardet-Biedl syndrome and certain genetic deficiencies, not for general obesity.","before":"A melanocortin-4 receptor agonist. This profile cites a U.S. label record.","field":"Profile summary"},{"after":"A randomized, placebo-controlled trial in 142 people with acquired hypothalamic obesity and smaller open-label trials in genetic forms of obesity are described in the label. The label states that it is not indicated for general obesity.","before":"The cited DailyMed label identifies Setmelanotide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.","field":"Evidence note"},{"after":"dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14, fda-drugs-nda213793-2020-11-25-5c2792fff70d","before":"dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14","field":"Cited source records"},{"after":"U.S. National Library of Medicine [sources: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14]; U.S. Food and Drug Administration [sources: fda-drugs-nda213793-2020-11-25-5c2792fff70d]","before":"U.S. National Library of Medicine [sources: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14]","field":"Named organizations"},{"after":"name: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14; aliases: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14; category: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14; status: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14, fda-drugs-nda213793-2020-11-25-5c2792fff70d; summary: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14, fda-drugs-nda213793-2020-11-25-5c2792fff70d; evidenceNote: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14","before":"name: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14; aliases: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14; category: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14; status: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14; summary: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14; evidenceNote: dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14","field":"Claim citations"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/setmelanotide/versions/3/","version":3},"id":"profile:setmelanotide:v3","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-status-changed","notice":"We added a plain-language reader guide with cited answers, re-checked the Imcivree label, and added the Drugs@FDA approval record.","peptideSlugs":["setmelanotide"],"previousChangeEvent":{"path":"/corrections/v1/profiles/setmelanotide/v2.json","sha256":"027518afc6c546133d3f3f28eb08bab462809d6c02852f3449e95717b887316c"},"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/setmelanotide/versions/2/","version":2},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14","name":"DailyMed · U.S. National Library of Medicine","sourceClass":"A","title":"IMCIVREE (setmelanotide) solution · SPL version 14 · published 2026-04-02","url":"https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9&version=14","verifiedAt":"2026-07-22"},{"id":"fda-drugs-nda213793-2020-11-25-5c2792fff70d","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA213793 · original submission status AP · 2020-11-25 · dataset 2026-08-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA213793%22&limit=1","verifiedAt":"2026-08-14"}],"subject":{"slug":"setmelanotide","type":"profile"}}
